Posted on June 17, 2013
On June 12, 2013, the U.S. Judicial Panel on Multidistrict Litigation (JPMDL) transferred more than 39 Stryker Rejuvenate and ABGII defective hip cases to the U.S. District Court of Minnesota. The MDL was approved to allow for coordination of pretrial discovery and to preserve judicial resources. The transferred cases, and any future Stryker Rejuvenate and ABG II hip lawsuits filed in federal court, are assigned to Judge Donavan W. Frank in Minnesota Federal Court (In Re: Stryker Rejuvenate and ABG II Hip Implant Products Liability Litigation, MDL No. 2441). Common issues such as design defect and the safety and effectiveness of the Stryker Rejuvenate and ABG II hip systems will be the focus of pre-trial discovery. The Stryker MDL was approved in order to prevent inconsistent rulings from multiple judges assigned to cases filed all over the country and to preserve the resources of the courts and the plaintiffs involved in these lawsuits.
In July of 2012, Stryker recalled the Rejuvenate and ABG II hip systems. Lawsuits filed to date allege injuries including tissue death, metallosis, loosening or early failure of the hip implant, damage to the bones and tissues surrounding the implant and the need for revision surgery to remove defective Stryker hip implants. Thornton Law Firm, LLP is investigating and filing cases on behalf of individuals who were implanted with the recalled Stryker Rejuvenate or ABG II hip system and have suffered injuries related to these devices. We offer a free, confidential evaluation of your potential Stryker Rejuvenate or ABGII hip claim. Please contact Stryker hip implant lawyer Marilyn McGoldrick at 1-888-341-1405.